Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 6, 1998

View Archived Issues

Company Profile: Ascent

Weekly fish consumption might reduce the risk of sudden cardiac death in men

Interleukin-1: a potential target for the treatment of atherosclerosis

Sonus: Q4 and FY 1997 highlights

Centocor: FY 1997 highlights

P&U receives three-year marketing exclusivity for Rogaine Extra Strength

NeoPharm to pursue FDA approval of Neomark

Roche and deCODE Genetics form genomics collaboration

DEHOP enters phase I for NHL

Icos: Q4 and FY 1997 highlights

BioCryst: Q4 and FY 1997 highlights

Dopamine transporter ligands prepared at CIS Bio

Anticoagulant apoB-100 fragment discovered at Royal Free Hospital

Boehringer Mannheim develops new agents for diabetes

Antiobesity and antidiabetic compounds claimed by American Home Products

Asta's new immunophilin ligands

Glaxo Wellcome's new NRTI highlighted at AIDS conference

Corlopam finally on the market -- U.S. is country of first launch

CV Therapeutics, Cleveland Clinic Foundation collaborate on study of CVT-313

Ilex initiates phase I testing of intoplicine

Promising laboratory findings and phase I results reported for Leukine

Migranal Nasal Spray now available in U.S.

First results described for novel aromatase inhibitor in phase I

Nitric oxide as a target in stroke therapy

Bristol-Myers Squibb and NeuroSearch expand agreement for Parkinson's drug

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...